세계의 고면역글로불린 시장 보고서(2025년)

Hyperimmune globulins are specialized preparations of antibodies enriched with specific antibodies against a particular pathogen or antigen. These preparations are obtained from the plasma of individuals who have high levels of antibodies against a specific infectious agent or toxin. They are utilized for passive immunization to confer immediate immunity against certain diseases, particularly in situations requiring prompt protection.

The primary types of hyperimmune globulins include hepatitis B hyperimmune globulin, rabies hyperimmune globulin, tetanus hyperimmune globulin, cytomegalovirus (CMV) hyperimmune globulin, varicella-zoster virus (VZV) hyperimmune globulin, respiratory syncytial virus (RSV) hyperimmune globulin, among others. Hepatitis B hyperimmune globulin, for example, is derived from the plasma of donors with high antibody titers against the hepatitis B virus. These preparations are administered via various routes such as intramuscular or intravenous, serving diverse applications across governmental, private, and other sectors.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hyperImmune globulin market research report is one of a series of new reports from The Business Research Company that provides hyperImmune globulin market statistics, including hyperImmune globulins industry global market size, regional shares, competitors with a hyperImmune globulin market share, detailed hyperImmune globulin market segments, market trends, and opportunities, and any further data you may need to thrive in the hyperImmune globulins industry. This hyperImmune globulin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperimmune globulins market size has grown strongly in recent years. It will grow from $1.91 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increased government support, rise in healthcare expenditures.

The hyperimmune globulins market size is expected to see strong growth in the next few years. It will grow to $2.71 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the increasing prevalence of infectious diseases, growing awareness about the benefits of hyperimmune globulin injections, increasing demand for immunoglobulins, rising prevalence of alpha-1 antitrypsin deficiency, rising incidence of immune deficiencies. Major trends in the forecast period include technological advancements and innovation, investment in research and development, demand for passive immunity treatments, advancements in plasma-derived therapies, and technological advancements in manufacturing.

The forecast of 7.1% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. infectious disease control by increasing costs for rabies and tetanus hyperimmune globulins sourced from Austria and Brazil, potentially delaying post-exposure prophylaxis and raising emergency care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The hyperimmune globulin market is set to grow due to the increasing prevalence of infectious diseases. These diseases, caused by pathogens such as viruses, bacteria, fungi, and parasites, are on the rise due to factors such as antimicrobial resistance, climate change, and population growth. Hyperimmune globulins play a crucial role in combating infectious diseases by providing immediate passive immunity through concentrated antibodies targeting specific pathogens. This aids in disease prevention or treatment, as seen in cases such as chronic hepatitis B, where the number of cases in the US increased by 17% from 2021 to 2022. Therefore, the growth of infectious diseases is directly impacting the hyperimmune globulin market.

Government efforts to advance healthcare research and development are poised to boost the hyperimmune globulins market in the coming years. These initiatives are escalating due to growing demand for innovative medical solutions and the necessity to confront emerging health issues. They play a crucial role in fostering the development and accessibility of hyperimmune globulins, particularly in combating specific infectious diseases effectively. For example, in 2022, the UK government allocated £260 million (US $270.65 million) through the Business, Energy, and Industrial Strategy (BEIS) and the Department of Health and Social Care (DHSC) to enhance healthcare research and manufacturing. This funding supports NHS-led health research, new privacy-preserving platforms for diagnostics and treatment, clinical research services, and also includes £60 million (US $63.60 million) to bolster life sciences manufacturing in the UK. Therefore, the increasing government focus on healthcare research and development is a key driver of the hyperimmune globulins market.

In April 2022, Grifols S.A., a pharmaceutical company based in Spain, acquired Biotest for an undisclosed sum. This acquisition positions Grifols to enhance and diversify its product portfolio, increase the availability of plasma therapies, operate the largest private European network of plasma centers with 87 centers, and stimulate revenue growth and margin expansion. Biotest, a biotechnology company based in Germany, specializes in hyperimmune globulins, which aligns with Grifols' strategic goals.

Major companies operating in the hyperimmune globulins market are F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., FFF Enterprises Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Omrix Biopharmaceuticals Ltd., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., BioCare Inc.

North America was the largest region in the hyperimmune globulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hyperimmune globulins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hyperimmune globulins market consists of sales of bayrab, hepaGam B, Tetanus Immune Globulin (TIG), variZIG, respiGam, and cytogam. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hyperimmune Globulins Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperimmune globulins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hyperimmune globulins ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hyperimmune globulins market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Hepatitis B Hyperimmune Globulin; Rabies Hyperimmune Globulin; Tetanus Hyperimmune Globulin; Cytomegalovirus (CMV) Hyperimmune Globulin; Varicella-Zoster Virus (VZV) Hyperimmune Globulin; Respiratory Syncytial Virus (RSV) Hyperimmune Globulin; Other Types
• 2) By Route Of Administration: Intramuscular; Intravenous
• 3) By Application: Government Institution; Private Sector; Other Applications
• Subsegments:
• 1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin; Intravenous Hepatitis B Hyperimmune Globulin
• 2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human); Rabies Immune Globulin (Equine)
• 3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human); Tetanus Immune Globulin (Equine)
• 4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation; Cmv Immune Globulin For Neonatal Infection
• 5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis; Vzv Immune Globulin For Immunocompromised Patients
• 6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children; Rsv Immune Globulin For Adults With Respiratory Conditions
• 7) By Other Types: Diphtheria Hyperimmune Globulin; Botulism Hyperimmune Globulin; Other Specialized Hyperimmune Globulins
• Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Takeda Pharmaceutical Company Limited; Baxter International Inc.; CSL Ltd.; Fresenius Kabi AG; Grifols SA; Octapharma AG; Shanghai RAAS Blood Products Co. Ltd.; Emergent BioSolutions Inc.; Kedrion Biopharma Inc.; LFB SA; Hualan Biological Engineering Inc.; FFF Enterprises Inc.; Taibang Biologic Group; Bio Products Laboratory (BPL) Ltd.; ADMA Biologics; Cangene Corporation; Kamada Ltd.; Saol Therapeutics Inc.; Omrix Biopharmaceuticals Ltd.; Shire; Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.; BioCare Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hyperimmune Globulins Market Characteristics

3. Hyperimmune Globulins Market Trends And Strategies

4. Hyperimmune Globulins Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hyperimmune Globulins Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hyperimmune Globulins PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hyperimmune Globulins Market Growth Rate Analysis
• 5.4. Global Hyperimmune Globulins Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hyperimmune Globulins Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hyperimmune Globulins Total Addressable Market (TAM)

6. Hyperimmune Globulins Market Segmentation

• 6.1. Global Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hepatitis B Hyperimmune Globulin
• Rabies Hyperimmune Globulin
• Tetanus Hyperimmune Globulin
• Cytomegalovirus (CMV) Hyperimmune Globulin
• Varicella-Zoster Virus (VZV) Hyperimmune Globulin
• Respiratory Syncytial Virus (RSV) Hyperimmune Globulin
• Other Types
• 6.2. Global Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular
• Intravenous
• 6.3. Global Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Government Institution
• Private Sector
• Other Applications
• 6.4. Global Hyperimmune Globulins Market, Sub-Segmentation Of Hepatitis B Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular Hepatitis B Hyperimmune Globulin
• Intravenous Hepatitis B Hyperimmune Globulin
• 6.5. Global Hyperimmune Globulins Market, Sub-Segmentation Of Rabies Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rabies Immune Globulin (Human)
• Rabies Immune Globulin (Equine)
• 6.6. Global Hyperimmune Globulins Market, Sub-Segmentation Of Tetanus Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tetanus Immune Globulin (Human)
• Tetanus Immune Globulin (Equine)
• 6.7. Global Hyperimmune Globulins Market, Sub-Segmentation Of Cytomegalovirus (Cmv) Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cmv Immune Globulin For Organ Transplantation
• Cmv Immune Globulin For Neonatal Infection
• 6.8. Global Hyperimmune Globulins Market, Sub-Segmentation Of Varicella-Zoster Virus (Vzv) Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vzv Immune Globulin For Post-Exposure Prophylaxis
• Vzv Immune Globulin For Immunocompromised Patients
• 6.9. Global Hyperimmune Globulins Market, Sub-Segmentation Of Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rsv Immune Globulin For Infants And Children
• Rsv Immune Globulin For Adults With Respiratory Conditions
• 6.10. Global Hyperimmune Globulins Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diphtheria Hyperimmune Globulin
• Botulism Hyperimmune Globulin
• Other Specialized Hyperimmune Globulins

7. Hyperimmune Globulins Market Regional And Country Analysis

• 7.1. Global Hyperimmune Globulins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hyperimmune Globulins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hyperimmune Globulins Market

• 8.1. Asia-Pacific Hyperimmune Globulins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hyperimmune Globulins Market

• 9.1. China Hyperimmune Globulins Market Overview
• 9.2. China Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hyperimmune Globulins Market

• 10.1. India Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hyperimmune Globulins Market

• 11.1. Japan Hyperimmune Globulins Market Overview
• 11.2. Japan Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hyperimmune Globulins Market

• 12.1. Australia Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hyperimmune Globulins Market

• 13.1. Indonesia Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hyperimmune Globulins Market

• 14.1. South Korea Hyperimmune Globulins Market Overview
• 14.2. South Korea Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hyperimmune Globulins Market

• 15.1. Western Europe Hyperimmune Globulins Market Overview
• 15.2. Western Europe Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hyperimmune Globulins Market

• 16.1. UK Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hyperimmune Globulins Market

• 17.1. Germany Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hyperimmune Globulins Market

• 18.1. France Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hyperimmune Globulins Market

• 19.1. Italy Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hyperimmune Globulins Market

• 20.1. Spain Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hyperimmune Globulins Market

• 21.1. Eastern Europe Hyperimmune Globulins Market Overview
• 21.2. Eastern Europe Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hyperimmune Globulins Market

• 22.1. Russia Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hyperimmune Globulins Market

• 23.1. North America Hyperimmune Globulins Market Overview
• 23.2. North America Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hyperimmune Globulins Market

• 24.1. USA Hyperimmune Globulins Market Overview
• 24.2. USA Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hyperimmune Globulins Market

• 25.1. Canada Hyperimmune Globulins Market Overview
• 25.2. Canada Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hyperimmune Globulins Market

• 26.1. South America Hyperimmune Globulins Market Overview
• 26.2. South America Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hyperimmune Globulins Market

• 27.1. Brazil Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hyperimmune Globulins Market

• 28.1. Middle East Hyperimmune Globulins Market Overview
• 28.2. Middle East Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hyperimmune Globulins Market

• 29.1. Africa Hyperimmune Globulins Market Overview
• 29.2. Africa Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hyperimmune Globulins Market Competitive Landscape And Company Profiles

• 30.1. Hyperimmune Globulins Market Competitive Landscape
• 30.2. Hyperimmune Globulins Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CSL Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Hyperimmune Globulins Market Other Major And Innovative Companies

• 31.1. Fresenius Kabi AG
• 31.2. Grifols SA
• 31.3. Octapharma AG
• 31.4. Shanghai RAAS Blood Products Co. Ltd.
• 31.5. Emergent BioSolutions Inc.
• 31.6. Kedrion Biopharma Inc.
• 31.7. LFB SA
• 31.8. Hualan Biological Engineering Inc.
• 31.9. FFF Enterprises Inc.
• 31.10. Taibang Biologic Group
• 31.11. Bio Products Laboratory (BPL) Ltd.
• 31.12. ADMA Biologics
• 31.13. Cangene Corporation
• 31.14. Kamada Ltd.
• 31.15. Saol Therapeutics Inc.

32. Global Hyperimmune Globulins Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hyperimmune Globulins Market

34. Recent Developments In The Hyperimmune Globulins Market

35. Hyperimmune Globulins Market High Potential Countries, Segments and Strategies

• 35.1 Hyperimmune Globulins Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hyperimmune Globulins Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hyperimmune Globulins Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer